Viking Therapeutics, Inc. (FRA:1VT)
28.01
+0.63 (2.28%)
At close: Jan 9, 2026
Viking Therapeutics Market Cap
Viking Therapeutics has a market cap or net worth of €3.11 billion as of January 9, 2026. Its market cap has decreased by -31.46% in one year.
Market Cap
3.11B
Enterprise Value
2.50B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€28.01
Market Cap Chart
Since April 29, 2015, Viking Therapeutics's market cap has increased from 73.59M to 3.11B, an increase of 4,124.54%. That is a compound annual growth rate of 41.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 3.11B | -8.21% |
| Dec 31, 2025 | 3.39B | -21.80% |
| Dec 31, 2024 | 4.33B | 157.18% |
| Dec 29, 2023 | 1.68B | 149.68% |
| Dec 30, 2022 | 674.52M | 113.16% |
| Dec 31, 2021 | 316.44M | -5.75% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 247.30B |
| Siemens Aktiengesellschaft | 197.59B |
| Allianz SE | 145.37B |
| Deutsche Telekom AG | 134.99B |
| Siemens Energy AG | 107.65B |
| Rheinmetall AG | 87.17B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 67.47B |
| Deutsche Bank Aktiengesellschaft | 63.02B |